ZHX2 and ovarian cancer: Analysis of copy number across different cancer types from The Cancer Genome Atlas (TCGA) showed that ZHX2 is amplified in various cancers, including ovarian cancer (~40%) and breast cancer (~15%) (Figure 1A).